88
Participants
Start Date
December 31, 2005
Primary Completion Date
March 31, 2011
Study Completion Date
February 28, 2014
Bevacizumab
10 mg/kg intravenously over 90 minutes every 2 weeks on a 28 day cycle. First dose is given over 90 minutes and subsequent doses are given over 30 minutes.
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda
National Cancer Institute (NCI)
NIH